P01 Rare presentation of CNS lupus: A case report
Kathleen Joy Cartel Abanilla, Philippines
P02 SAPHO (Synovitis, Acne, Pustolosis, Hyperostosis, Osteitis) syndrome in a Filipino adolescent male successfully treated with infliximab
Ivy Joy Alberca, Philippines
P03 Comparison of the efficacy and safety of celbesta® versus celebrex® in patients with rheumatoid arthritis: A 6-week, multicenter, double-blinded, active-controlled, double dummy, randomized, parallel-group, non-inferiority clinical trial
Wonho Choi, South Korea
P04 Catastrophic antiphospholipid syndrome with renal impairment  treated with Truxima®
Wonho Choi, South Korea
P05 Atypical femoral fracture due to chronic use of antiresorptive therapy in a patient  with glucocorticoid-dependent systemic lupus erythematosus
Kay Hau Choy, Australia
P06 The effectiveness of curcuma longa in the treatment of knee osteoarthritis: A meta-analysis
Guntur Darmawan, Indonesia
P07 Nasopharyngeal cancer in primary Sjogren’s syndrome: A case report
Dominic dela Cruz,
P08 Coexistence of diffuse idiopathic skeletal hyperostosis and sacroiliitis in a young man presenting with chronic low back pain
Cassandra Elazegui-Machuca, Philippines
P09 Impact of nutritional supplement on bone turnover markers in Indian, healthy, premenopausal women (25 to 45 years, inclusive) after 6 months intervention: A randomized double-blind controlled trial
Vivek Garg, India
P10 Comparative effectiveness of tofacitinib and TNF inhibitors since 2014. Impact of combination with methotrexate
Boulos Haraoui, Canada
P11 Comparative effectiveness of tofacitinib and non-TNF agents since 2014. Impact of combination with MTX
Boulos Haraoui, Canada
P12 The factor affecting the periods of the conservative therapy in frozen shoulder
Takashi Hashiba, Japan
P13 Hypothyroid and hyperthyroid status was strongly associated with musculoskeletal ultrasonographic abnormalities with arthralgia
Bo Young Kim, South Korea
P14 STAT3 activated by TGF-β1 is involved in endochondral ossification in mice
Gunwoo Kim, South Korea
P15 Effectiveness of whole body vibration on bone mineral density in elderly women
Aung Ko Oo, Myanmar
P16 Association between adipsin/MCP-1 ratio with cartilage volume loss and CRP/MCP-1 with symptoms in obese knee osteoarthritis subjects
Johanne Martel-Pelletier, Canada
P17 Developing a comprehensive patient-specific disease progression prediction model for knee osteoarthritis using machine/deep learning methods
Johanne Martel-Pelletier, Canada
P18 Hyperprolactinemia and pituitary microadenoma in a lupus patient: A case report
Bethlehem Mula, Philippines
P19 The relationship between power doppler signal and disease activity markers in patients with active synovitis
Seoung Wan Nam, South Korea
P20 Syndrome of inapproriate secretion of anti-diuretic hormone and acute obstructing hydrocephalus in a lupus patient with prolonged fever
Gerald Natanauan, Philippines
P21 Epidemiology of juvenile systemic lupus erythematosus: Incidence, prevalence and age of onset
Seonghoon Park, South Korea
P22 Diacerein as effective as celecoxib in treating symptoms in knee osteoarthritis patients: Results from an international, multicentre, double-blind, randomised study (DISSCO)
Jean-Pierre Pelletier, Canada
P23 Anti-DFS70 antibody frequency in patients with undifferentiated connective tissue disease
Diana Rincon, Colombia
P24 Ossification of the transverse ligament of Atlas: Frequency and associated findings
JeongAh Ryu, South Korea
P25 Hip bone density predicts breast cancer risk independently from the Tyrer-Cuzick risk model in women at increased risk of developing the disease
Ivana Sestak, UK
P26 Effect of tumor necrosis factor α inhibitors on sclerostin and Dkk-1 in ankylosing spondylitis
Min Wook So, South Korea
P27 Synovial fluid proteomics in ankylosing spondylistis
Chang-Nam Son, South Korea
P28 Serial administration of rhBMP-2 and alendronate enhance differentiation of osteoblastic MC3T3-E1 cells
Byung Wook Song, South Korea
P29 Lorecivivint (SM04690): An intra-articular Wnt pathway inhibitor for knee osteoarthritis treatment: Phase 2b patient-reported outcomes
Jeyanesh Tambiah, USA
P30 Prospective comparison of sham vs. placebo injections: Data from a trial of lorecivivint, a Wnt pathway inhibitor for knee osteoarthritis
Jeyanesh Tambiah, USA
P31 Comparison of the efficacy and safety of tofacitinib and upadacitinib in patients with active rheumatoid arthritis: A network meta-analysis
Young Ho Lee, South Korea
P32 Refractory angioedema due to hypocomplementemic urticarial vasculitis in systemic lupus erythematosus successfully treated with rituximab
Annabel Joy Yap, Philippines
P33 Serum lysophosphatidylchlines to phosphatidylcholines ratio is associated with symptomatic responders to symptomatic drugs in knee osteoarthritis patients
Guangju Zhai, Canada